Medicine composition for treating hyperplasia of mammary glands and preparation method thereof

Abstract

The invention discloses a pharmaceutical composition for treating breast hyperplasia, and the pharmaceutical composition is composed of raw rehmannia root, costustoot, figwort root, blister beetle, forsythia, rhubarb, Japanese ampelopsis root, tangerine peel, green tangerine peel, raw liquoric root, unibract fritillary bulb and other medicines. The pharmaceutical composition has the effect on activating blood circulation, removing blood stasis, activating qi and relieving pain for treating the breast hyperplasia and can expand the capillary vessels, accelerate the blood flow velocity and improve the microcirculation; the pharmaceutical composition can rapidly get through the obstructed glandular tubes and gradually soften the masses till the disappearance, patients can be recovered completely and the relapse is difficult after the healing.

Description

technical field

[0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating mammary gland hyperplasia and a preparation method thereof. Background technique

[0002] Mammary gland hyperplasia is the structural degeneration of breast tissue ducts and milk lobules and the growth of progressive connective tissue. The main cause of the disease is the imbalance of endocrine hormones. Since mammary gland hyperplasia is mainly caused by hormone imbalance, the treatment should start with regulating endocrine. Traditional Chinese medicine believes that women often suffer from deficiency of qi and blood, coupled with factors such as emotional changes, which can easily lead to stagnation of qi and blood stasis, blockage of meridians, metabolic waste deposits in the breast, and development of breast lumps, that is, breast adenosis. Breast hyperplasia is the most common breast disease in women, and its incidence rate accounts ...